OP Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.7M Sell
197,569
-113,333
-36% -$24.4M 0.53% 33
2026
Q1
$67.6M Buy
310,902
+116,145
+60% +$25.8M 0.68% 24
2025
Q4
$44.5M Sell
194,757
-14,269
-7% -$3.25M 0.53% 28
2025
Q3
$48.4M Buy
209,026
+3,727
+2% +$759K 0.62% 27
2025
Q2
$38.1M Buy
205,299
+6,719
+3% +$1.25M 0.55% 28
2025
Q1
$41.6M Buy
+198,580
New +$38.6M 0.68% 25

Other funds holding ABBV

OP Asset Management's ABBV Position: Q2 2026 in Review

OP Asset Management reduced its AbbVie (ABBV) stake by 36% in Q2 2026, selling an estimated $24.4M and leaving 197,569 shares worth $49.7M. The position accounts for 0.53% of the portfolio, ranked #33.

OP Asset Management first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $67.6M in Q1 2026. 4,217 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • OP Asset Management held 197,569 shares of AbbVie worth $49.7M as of Q2 2026.
  • OP Asset Management sold 113,333 AbbVie shares in Q2 2026, an estimated $24.4M.
  • AbbVie made up 0.53% of OP Asset Management's portfolio in Q2 2026, its #33 holding.
  • OP Asset Management first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's AbbVie position peaked at $67.6M in Q1 2026.
  • 4,217 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.